Weller, M., Berry, D., Blondin, N., Boulmay, B., Buxton, M., Chinot, O., … Cloughesy, T. (2024). P27.11.A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. In Neuro-Oncology (Vol. 26, pp. v139–v139). Oxford University Press (OUP). https://doi.org/10.1093/neuonc/noae144.473

Weller, M., D. Berry, N. Blondin, B. Boulmay, M. Buxton, O. Chinot, H. Colman, et al. “P27.11.A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.” In Neuro-Oncology, 26:v139–v139. Oxford University Press (OUP), 2024. https://doi.org/10.1093/neuonc/noae144.473.

Weller M, Berry D, Blondin N, Boulmay B, Buxton M, Chinot O, et al. P27.11.A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. In: Neuro-Oncology. Oxford University Press (OUP); 2024. p. v139–v139.

Weller, M., et al. “P27.11.A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA.” Neuro-Oncology, vol. 26, no. Supplement_5, Oxford University Press (OUP), 2024, pp. v139–v139. Crossref, doi:10.1093/neuonc/noae144.473.

Weller M, Berry D, Blondin N, Boulmay B, Buxton M, Chinot O, Colman H, de la Fuente M, de Groot J, Drappatz J, Ducray F, Ellingson B, Galldiks N, Gordon G, Hau P, Hottinger A, Hyddmark V, Khasraw M, Kim L, Lassman A, Lee E, Lim M, Mellinghoff I, Mikkelson T, Nghiemphu P, Perry J, Ronellenfitsch M, Sulman E, Tabatabai G, Tanner K, Touat M, Wen PY, Wick A, Yung W, Cloughesy T. P27.11.A GLOBAL EXPANSION OF GBM AGILE: A PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA. Neuro-Oncology. Oxford University Press (OUP); 2024. p. v139–v139.